It’s not just tech stocks that have struggled this FY, the “Certainty Trade” as it was labelled into June has largely been hammered from CBA to JB Hi-Fi. Another example is Pro Medicus (PME) which soared higher into June, ignoring valuation concerns, only to tumble ~28% in FY26 even as it continues to win new contracts but an Est. 164x valuation for FY26 its valuation remains daunting with rates set to increase.
- We are looking for a break/test of $240 in the coming weeks as the high growth stocks remain heavy – in the case of PME a break of $200 would not surprise.